2 terminated. 2 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 2 | Terminated 2 |
Follow Sofosbuvir: new trials by email Literature Review of Sofosbuvir trials Research Report on Sofosbuvir
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Early Treatment With Sofosbuvir (SOF) and Ledipasvir (LDV) to Prevent HCV Recurrence After Liver Transplantation (OLT) Sofosbuvir (SOF) and Ledipasvir (LDV) - Hepatitis C Viral Infection | Phase 3 | Terminated | University Health Network, Toronto | 1 | 2015-06-01 | 2016-08-08 |
| Reversal of Hepatic Impairment in Patients With Hepatitis C Virus (HCV) and Early Decompensation of Cirrhosis Simeprivir (SMV), Sofosbuvir (SOF), Ribavirin (RBV) - Hepatitis C | Phase 3 | Terminated | University of Colorado, Denver | 9 | 2015-05-01 | 2021-09-13 |
Hepatitis C (1)
University Health Network, Toronto (1) · University of Colorado, Denver (1)
Canada (1) · United States (1)
Amanda Wieland, MD (1) · Eberhard Renner, M.D. (1)
PMID 17593061, PMID 17635375, PMID 17850410, PMID 18266997, PMID 19053983, PMID 8213790, PMID 9346731
UL1TR001082 (1)